354 related articles for article (PubMed ID: 33197504)
1. LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
Zhou Y; Ge Y; Liu Q; Li YX; Chao X; Guan JJ; Diwu YC; Zhang Q
Neuroscience; 2021 Feb; 455():52-64. PubMed ID: 33197504
[TBL] [Abstract][Full Text] [Related]
2. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ
Ge Y; Song X; Liu J; Liu C; Xu C
Neurochem Res; 2020 Apr; 45(4):741-751. PubMed ID: 31898085
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA BACE1-AS Modulates Isoflurane-Induced Neurotoxicity to Alzheimer's Disease Through Sponging miR-214-3p.
He W; Chi S; Jin X; Lu J; Zheng W; Yan J; Zhang D
Neurochem Res; 2020 Oct; 45(10):2324-2335. PubMed ID: 32681443
[TBL] [Abstract][Full Text] [Related]
4. Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124.
Yue D; Guanqun G; Jingxin L; Sen S; Shuang L; Yan S; Minxue Z; Ping Y; Chong L; Zhuobo Z; Yafen W
Cell Biol Int; 2020 Feb; 44(2):630-636. PubMed ID: 31743528
[TBL] [Abstract][Full Text] [Related]
5. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
6. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA BACE1-antisense transcript plays a critical role in Parkinson's disease via microRNA-214-3p/Cell death-inducing p53-target protein 1 axis.
Li L; Wang H; Li H; Lu X; Gao Y; Guo X
Bioengineered; 2022 Apr; 13(4):10889-10901. PubMed ID: 35481549
[TBL] [Abstract][Full Text] [Related]
9. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
Zhang J; Wang R
Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
[TBL] [Abstract][Full Text] [Related]
10. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
Wang X; Li M; Hu Y
Physiol Res; 2023 Dec; 72(6):833-841. PubMed ID: 38215068
[TBL] [Abstract][Full Text] [Related]
11. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA SOX21-AS1 attenuates amyloid-β-induced neuronal damage by sponging miR-107.
Xu W; Li K; Fan Q; Zong B; Han L
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32124921
[TBL] [Abstract][Full Text] [Related]
13. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway.
Sha S; Shen X; Cao Y; Qu L
Aging (Albany NY); 2021 Jun; 13(11):15285-15306. PubMed ID: 34086603
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products induce Aβ
Jiang L; Yuan N; Zhao N; Tian P; Zhang D; Qin Y; Shi Z; Gao Z; Zhang N; Zhou H; Zhang R; Xu S
Brain Res Bull; 2022 Oct; 188():187-196. PubMed ID: 35961529
[TBL] [Abstract][Full Text] [Related]
16. The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer's and Parkinson's Diseases.
Talebi Taheri A; Golshadi Z; Zare H; Alinaghipour A; Faghihi Z; Dadgostar E; Tamtaji Z; Aschner M; Mirzaei H; Tamtaji OR; Nabavizadeh F
Cell Mol Neurobiol; 2024 Mar; 44(1):28. PubMed ID: 38461204
[TBL] [Abstract][Full Text] [Related]
17. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
He L; Chen Z; Wang J; Feng H
BMC Neurol; 2022 Jun; 22(1):203. PubMed ID: 35659599
[TBL] [Abstract][Full Text] [Related]
18. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
Ji Y; Wang D; Zhang B; Lu H
J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA AK139328 alleviates myocardial ischaemia/reperfusion injury in diabetic mice via modulating miR-204-3p and inhibiting autophagy.
Yu SY; Dong B; Fang ZF; Hu XQ; Tang L; Zhou SH
J Cell Mol Med; 2018 Oct; 22(10):4886-4898. PubMed ID: 30047214
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation
Wang L; Liu J; Wang Q; Jiang H; Zeng L; Li Z; Liu R
Front Pharmacol; 2019; 10():806. PubMed ID: 31379578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]